Tamoxifen Citrate
Pharmaceutical Secondary Standard; Certified Reference Material, certified reference material, pharmaceutical secondary standard, pkg of 300 mg
Manufacturer: Supelco
CAS Number: 54965-24-1
Synonym(S): Tamoxifen citrate salt, (Z)-1-(p-Dimethylaminoethoxyphenyl)-1,2-diphenyl-1-butene
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| 300 MG | PHR2706-300-MG | In Stock | ₹ 20,437.60 |
PHR2706 - 300 MG
In Stock
Quantity
1
Base Price: ₹ 20,437.60
GST (18%): ₹ 3,678.768
Total Price: ₹ 24,116.368
grade
certified reference materialpharmaceutical secondary standard
Quality Level
300
Agency
traceable to BP BP1225traceable to Ph. Eur. T0014000traceable to USP 1643306
API family
tamoxifen
form
solid
CofA
current certificate can be downloaded
packaging
pkg of 300 mg
application(s)
pharmaceutical small molecule
storage temp.
2-8°C
SMILES string
OC(=O)CC(O)(CC(O)=O)C(O)=O.CC\C(c1ccccc1)=C(/c2ccccc2)c3ccc(OCCN(C)C)cc3
Other Options
| Image | Product Name | Manufacturer | Price Range | |
|---|---|---|---|---|
 | MilliporeSigma™ Calbiochem™ Tamoxifen Citrate | -- | ₹ 6,684.80 | |
| | Enzo Life Sciences Tamoxifen. citrate (1g). CAS: 54965-24-1 | -- | ₹ 14,168.74 | |
| | eMolecules Medchem Express / Tamoxifen (Citrate) / 500mg / 446263448 / HY-13757 / / 54965-24-1 / MFCD00058321 / 563.647 / C32H37NO8 | -- | ₹ 8,312.15 | |
| | Tamoxifen citrate | -- | ₹ 40,756.13 | |
| | Tamoxifen citrate for performance test | -- | ₹ 16,107.60 | |
| | 54965-24-1 | Ethanamine, 2-[4-(1,2-diphenyl-1-butenyl)phenoxy]-N,N-dimethyl-, (Z)-,2-hydroxy-1,2,3-propanetricarboxylate (1:1) | -- | ₹ 2,909.04 - ₹ 37,304.16 |
Related Products
Description
- General description: Pharmaceutical secondary standards for application in quality control provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards.
- Application: These Secondary Standards are qualified as Certified Reference Materials. These are suitable for use in several analytical applications including but not limited to pharma release testing, pharma method development for qualitative and quantitative analyses, food and beverage quality control testing, and other calibration requirements.
- Biochem/physiol Actions: Protein kinase C inhibitor. Induces apoptosis in human malignant glioma cell lines. Tamoxifen and its metabolite 4-hydroxytamoxifen are selective estrogen response modifiers (SERMs) that act as estrogen antagonists in mammary gland. Blocks estradiol-stimulated VEGF production in breast tumor cells.
- Analysis Note: These secondary standards offer multi-traceability to the USP, EP and BP primary standards, where they are available.
- Other Notes: This Certified Reference Material (CRM) is produced and certified in accordance with ISO 17034 and ISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis.
SAFETY INFORMATION
Pictograms
Signal Word
Danger
Hazard Statements
Precautionary Statements
Hazard Classifications
Acute Tox. 4 Oral - Aquatic Acute 1 - Aquatic Chronic 1 - Carc. 1B - Repr. 1B
WGK
WGK 3
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable